APA (7th ed.) Citation

Hmedat, A. N. A., Doondeea, J., Ebner, D., Feller, S. M., & Lewitzky, M. The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity. BMC.

Chicago Style (17th ed.) Citation

Hmedat, Ali N. A., Jessica Doondeea, Daniel Ebner, Stephan M. Feller, and Marc Lewitzky. The Src Family Kinase Inhibitor Drug Dasatinib and Glucocorticoids Display Synergistic Activity Against Tongue Squamous Cell Carcinoma and Reduce MET Kinase Activity. BMC.

MLA (9th ed.) Citation

Hmedat, Ali N. A., et al. The Src Family Kinase Inhibitor Drug Dasatinib and Glucocorticoids Display Synergistic Activity Against Tongue Squamous Cell Carcinoma and Reduce MET Kinase Activity. BMC.